Exclusive

Publication

Byline

Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, March 26 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate... Read More


Sri Lankan arrested at BIA for smuggling 38 exotic pets

Sri Lanka, March 26 -- A Sri Lankan passenger who attempted to smuggle 38 exotic pets estimated to be worth nearly Rs. 1 million into the country, in violation of the Fauna and Flora Protection Ordina... Read More


Telangana: CM Revanth Reddy to virtually address AI symposium at Harvard Kennedy School

Hyderabad, March 26 -- Telangana Chief Minister Revanth Reddy will virtually deliver a keynote address at a first-of-its-kind Artificial Intelligence (AI) Symposium organised by Harvard Kennedy in Bos... Read More


Want glossy, shiny lips? These 7 shimmery lipsticks are total game-changers

India, March 26 -- Lipstick is an instant mood booster. A single swipe of your favourite shade can lift your spirits, brighten your look, and add a touch of confidence to even the gloomiest days. No m... Read More


Singapore flags 'falsehoods' in The Online Citizen report on IDF claims, launches police probe

SINGAPORE, March 26 -- Singapore police are investigating an article published by The Online Citizen (TOC) over claims that Singaporeans had served in the Israeli Defence Forces (IDF), as authorities ... Read More


Prashant Kishor Slams Nitish Kumar Over Son's JD(U) Entry, Questions 'Moral High Ground'

India, March 26 -- Jan Suraaj Party founder Prashant Kishor has launched a sharp attack on Bihar Chief Minister Nitish Kumar, alleging that his re-election as JD(U) national president and the inductio... Read More